RNA
Price:
$31.21
Market Cap:
$3.72B
Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic muscle disease; AOC 1044 for the treatment of Duchenne Muscular Dystrophy; and AOC 1020 designed to treat facioscapulohumeral muscular dystrophy which are in preclinical stage. It also offers Lumizyme therapy for Pompe diseases. Avidity Biosciences, Inc. was incorporated in 2012 and is headquartered in San Diego, California.[Read more]
Industry
Biotechnology
IPO Date
2020-06-12
Stock Exchange
NASDAQ
Ticker
RNA
According to Avidity Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -27.66%. This represents a change of 251.22% compared to the average of -7.88% of the last 4 quarters.
The mean historical ROE of Avidity Biosciences, Inc. over the last ten years is -6.43%. The current -27.66% ROE has changed 329.98% with respect to the historical average. Over the past ten years (40 quarters), RNA's ROE was at its highest in in the March 2019 quarter at 30.22%. The ROE was at its lowest in in the June 2022 quarter at -12.21%.
Average
-6.43%
Median
-21.81%
Minimum
-42.38%
Maximum
49.15%
Discovering the peaks and valleys of Avidity Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 114.24%
Maximum Annual ROE = 49.15%
Minimum Annual Increase = -129.22%
Minimum Annual ROE = -42.38%
Year | ROE | Change |
---|---|---|
2023 | -42.38% | 44.89% |
2022 | -29.25% | -4.95% |
2021 | -30.77% | 114.24% |
2020 | -14.36% | -129.22% |
2019 | 49.15% | 69.38% |
The current ROE of Avidity Biosciences, Inc. (RNA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-34.13%
5-year avg
-13.52%
10-year avg
-6.43%
Avidity Biosciences, Inc.’s ROE is greater than TCR2 Therapeutics Inc. (-71.90%), greater than Revolution Medicines, Inc. (-33.67%), greater than Black Diamond Therapeutics, Inc. (-68.08%), greater than Atreca, Inc. (-199.88%), greater than Passage Bio, Inc. (-72.53%), greater than Akero Therapeutics, Inc. (-32.52%), less than Protagonist Therapeutics, Inc. (34.68%), greater than Stoke Therapeutics, Inc. (-54.45%), greater than IGM Biosciences, Inc. (-155.42%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Cullinan Oncology, Inc. (-26.54%), greater than Mineralys Therapeutics, Inc. (-55.92%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than SpringWorks Therapeutics, Inc. (-48.21%), greater than Relay Therapeutics, Inc. (-45.75%), greater than Pliant Therapeutics, Inc. (-48.91%), greater than Arvinas, Inc. (-50.26%),
Company | ROE | Market cap |
---|---|---|
-71.90% | $58.11M | |
-33.67% | $8.04B | |
-68.08% | $121.66M | |
-199.88% | $3.57M | |
-72.53% | $40.35M | |
-32.52% | $2.00B | |
34.68% | $2.35B | |
-54.45% | $598.00M | |
-155.42% | $375.52M | |
-98.94% | $8.19B | |
-26.54% | $709.79M | |
-55.92% | $620.62M | |
-22.40% | $1.27B | |
-48.21% | $2.77B | |
-45.75% | $702.17M | |
-48.91% | $816.05M | |
-50.26% | $1.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Avidity Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Avidity Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Avidity Biosciences, Inc.'s ROE?
How is the ROE calculated for Avidity Biosciences, Inc. (RNA)?
What is the highest ROE for Avidity Biosciences, Inc. (RNA)?
What is the 3-year average ROE for Avidity Biosciences, Inc. (RNA)?
What is the 5-year average ROE for Avidity Biosciences, Inc. (RNA)?
How does the current ROE for Avidity Biosciences, Inc. (RNA) compare to its historical average?